Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
28.22
-0.49 (-1.71%)
At close: Apr 28, 2026, 4:00 PM EDT
28.22
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.85 billion as of April 28, 2026. Its market cap has increased by 184.64% in one year.
Market Cap
1.85B
Enterprise Value
1.50B
1-Year Change
184.64%
Ranking
Category
Stock Price
$28.22
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.85B, an increase of 189.86%. That is a compound annual growth rate of 22.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.88B | 4.17% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.99B |
| Mesoblast | 1.99B |
| Inhibrx Biosciences | 1.92B |
| AnaptysBio | 1.91B |
| Galapagos NV | 1.89B |
| Vericel | 1.88B |
| Taysha Gene Therapies | 1.86B |
| Syndax Pharmaceuticals | 1.85B |